Aardvark Therapeutics Inc

AARDNASDAQ · USD
1.19USD-0.07 (-5.56%)
222

Aardvark Therapeutics Inc (AARD) Implied Volatility Current

Read more

Tracking AARD implied volatility helps you spot when Aardvark Therapeutics Inc options are historically cheap or expensive, and where the best trades are hiding. When AARD IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor AARD implied volatility current levels in real time and filter for high probability trades.

Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking AARD IV rank helps you see whether AARD's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is the ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen that is in Phase III clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in Phase II clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from treatment of craniopharyngioma, including surgery or radiation.

Implied Volatility

IV Rank
—IV Rank
—
Implied Volatility (30d)89.48%

IV Rank—

Historical Volatility (30d)336.12%

IV Minus HV-246.64%

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →